Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 15;8(12):2603-2615.
doi: 10.1016/j.ekir.2023.09.007. eCollection 2023 Dec.

Patient Survival With Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis

Collaborators, Affiliations

Patient Survival With Extended Home Hemodialysis Compared to In-Center Conventional Hemodialysis

Ercan Ok et al. Kidney Int Rep. .

Abstract

Introduction: More frequent and/or longer hemodialysis (HD) has been associated with improvements in numerous clinical outcomes in patients on dialysis. Home HD (HHD), which allows more frequent and/or longer dialysis with lower cost and flexibility in treatment planning, is not widely used worldwide. Although, retrospective studies have indicated better survival with HHD, this issue remains controversial. In this multicenter study, we compared thrice-weekly extended HHD with in-center conventional HD (ICHD) in a large patient population with a long-term follow-up.

Methods: We matched 349 patients starting HHD between 2010 and 2014 with 1047 concurrent patients on ICHD by using propensity scores. Patients were followed-up with from their respective baseline until September 30, 2018. The primary outcome was overall survival. Secondary outcomes were technique survival; hospitalization; and changes in clinical, laboratory, and medication parameters.

Results: The mean duration of dialysis session was 418 ± 54 minutes in HHD and 242 ± 10 minutes in patients on ICHD. All-cause mortality rate was 3.76 and 6.27 per 100 patient-years in the HHD and the ICHD groups, respectively. In the intention-to-treat analysis, HHD was associated with a 40% lower risk for all-cause mortality than ICHD (hazard ratio [HR] = 0.60; 95% confidence interval [CI] 0.45 to 0.80; P < 0.001). In HHD, the 5-year technical survival was 86.5%. HHD treatment provided better phosphate and blood pressure (BP) control, improvements in nutrition and inflammation, and reduction in hospitalization days and medication requirement.

Conclusion: These results indicate that extended HHD is associated with higher survival and better outcomes compared to ICHD.

Keywords: hemodialysis; home hemodialysis; hospitalization; matched case-control study; medication requirement; survival.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1
Figure 1
Flow chart of the study. FMC, Fresenius Medical Care; HD, hemodialysis; HHD, home hemodialysis; ICHD, in-center conventional HD.
Figure 2
Figure 2
Kaplan Meier survival analyses in the HHD and the ICHD groups. (a) Intention-to-treat; and (b) as-treated. HHD, home hemodialysis; ICHD, in-center conventional HD.
Figure 3
Figure 3
Technique survival analyses in the HHD group. (a) Death and transplantation-censored technique survival. (b) Composite technique survival. HD, hemodialysis; HHD, home hemodialysis.
Figure 4
Figure 4
Forest plot (subgroup analyses). BMI, body mass index; ESRD, end-stage renal disease; HD, hemodialysis.

References

    1. Chertow G.M., Levin N.W., Beck G.J., et al. In-center hemodialysis six times per week versus three times per week. N Engl J Med. 2010;363:2287–2300. doi: 10.1056/NEJMoa1001593. - DOI - PMC - PubMed
    1. Culleton B.F., Walsh M., Klarenbach S.W., et al. Effect of frequent nocturnal hemodialysis vs conventional hemodialysis on left ventricular mass and quality of life: a randomized controlled trial. JAMA. 2007;298:1291–1299. doi: 10.1001/jama.298.11.1291. - DOI - PubMed
    1. Ok E., Duman S., Asci G., et al. Comparison of 4- and 8-h dialysis sessions in thrice-weekly in-centre haemodialysis: a prospective, case-controlled study. Nephrol Dial Transplant. 2011;26:1287–1296. doi: 10.1093/ndt/gfq724. - DOI - PubMed
    1. Lacson E., Jr., Xu J., Suri R.S., et al. Survival with three-times weekly in-center nocturnal versus conventional hemodialysis. J Am Soc Nephrol. 2012;23:687–695. doi: 10.1681/ASN.2011070674. - DOI - PMC - PubMed
    1. Raj D.S., Ouwendyk M., Francoeur R., Pierratos A. Beta (2)-microglobulin kinetics in nocturnal haemodialysis. Nephrol Dial Transplant. 2000;15:58–64. doi: 10.1093/ndt/15.1.58. - DOI - PubMed

LinkOut - more resources